Curebase, Flow Neuroscience Announce Joint Clinical Trial for the use of an at-home tDCS device for treating depression ...Middle East

PR Newswire - News
Curebase, Flow Neuroscience Announce Joint Clinical Trial for the use of an at-home tDCS device for treating depression
SAN FRANCISCO and MALMO, Sweden, May 17, 2022 /PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, and Flow Neuroscience, creator of Europe's only medically approved transcranial direct current stimulation (tDCS) device and behavioral therapy app for...

Hence then, the article about curebase flow neuroscience announce joint clinical trial for the use of an at home tdcs device for treating depression was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Curebase, Flow Neuroscience Announce Joint Clinical Trial for the use of an at-home tDCS device for treating depression )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News